MAPK8 and neuroblastoma: To further understand the nature of nongenetic chemoresistance in neuroblastoma, we previously performed patient-specific computational simulations of chemotherapy-induced c-Jun N-terminal kinase (JNK) signaling in neuroblastoma tumors (8).